Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Merck
Baxter
Argus Health
Mallinckrodt
US Army
Covington
Cerilliant
Healthtrust
Accenture

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078848

« Back to Dashboard

NDA 078848 describes BENAZEPRIL HYDROCHLORIDE, which is a drug marketed by Actavis Labs Fl Inc, Amneal Pharms, Apotex Inc, Aurobindo Pharma, Genpharm, Ivax Sub Teva Pharms, Mylan, Prinston Inc, Sandoz, Sun Pharm Inds Ltd, Teva, Zydus Pharms Usa, and Mylan Pharms Inc, and is included in nineteen NDAs. It is available from forty-one suppliers. Additional details are available on the BENAZEPRIL HYDROCHLORIDE profile page.

The generic ingredient in BENAZEPRIL HYDROCHLORIDE is benazepril hydrochloride; hydrochlorothiazide. There are fourteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the benazepril hydrochloride; hydrochlorothiazide profile page.
Summary for 078848
Tradename:BENAZEPRIL HYDROCHLORIDE
Applicant:Zydus Pharms Usa
Ingredient:benazepril hydrochloride
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 078848
Suppliers and Packaging for NDA: 078848
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 078848 ANDA Zydus Pharmaceuticals (USA) Inc. 68382-169 N 68382-169-01
BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 078848 ANDA Zydus Pharmaceuticals (USA) Inc. 68382-169 N 68382-169-16

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:May 23, 2008TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:May 23, 2008TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:May 23, 2008TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
US Army
Medtronic
Federal Trade Commission
Chubb
Covington
McKinsey
US Department of Justice
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot